title: Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma.
authors.affiliation: Harvard Medical School, Boston, Massachusetts.
authors.forename: Dawn E
authors.initials: DE
authors.lastname: Comstock
authors.affiliation: Harvard Medical School, Boston, Massachusetts2Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts3Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Mizuki
authors.initials: M
authors.lastname: Nishino
authors.affiliation: Harvard Medical School, Boston, Massachusetts2Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts3Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Angela A
authors.initials: AA
authors.lastname: Giardino
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D000072659:Hypophysitis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D007167:Immunotherapy / Q000009:adverse effects* / Q000379:methods; D000074324:Ipilimumab / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D000077594:Nivolumab / Q000008:administration & dosage
chemical_list: D000074324:Ipilimumab; D000077594:Nivolumab; D006854:Hydrocortisone